Latest News

Investigating Links Between Cancer and Psoriasis Management
Investigating Links Between Cancer and Psoriasis Management

November 22nd 2023

Because of the chronic inflammatory state of psoriasis and the immunosuppression produced by some systemic medications, patients with psoriasis may have an increased risk of lymphoma and nonmelanoma skin cancer.

No Significant Difference in BMI, Weight Regarding Switching Rates for Patients with Psoriasis
No Significant Difference in BMI, Weight Regarding Switching Rates for Patients with Psoriasis

November 15th 2023

UCB's Bimekizumab is Now Available
UCB's Bimekizumab is Now Available

November 14th 2023

Tildrakizumab Significantly Improved Work Productivity and More in Patients With Plaque Psoriasis
Tildrakizumab Significantly Improved Work Productivity and More in Patients With Plaque Psoriasis

November 14th 2023

Patients With Mild Psoriasis Experience Less Favorable Status at Diagnosis and First Line of Treatment
Patients With Mild Psoriasis Experience Less Favorable Status at Diagnosis and First Line of Treatment

November 9th 2023

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

More News

© 2023 MJH Life Sciences

All rights reserved.